Literature DB >> 26377265

3-D Isotropic MR Imaging for Planning Bone Reconstruction in Patients With Femoroacetabular Impingement.

Shaun Nordeck, Jennifer Flanagan, Lulu Tenorio, William Robertson, Avneesh Chhabra.   

Abstract

BACKGROUND: Femoroacetabular impingement (FAI) is commonly seen in young or middle-aged patients. Early detection and correction of FAI-related bony deformities or pelvic realignment are essential to prevent the development or progression of hip osteoarthritis. DISCUSSION: Computed tomography (CT) and magnetic resonance (MR) imaging are the reference standards for the evaluation of bony anatomy and treatable internal derangement findings of the hip, respectively. Surgeons prefer CT imaging for preoperative bone delineation because of its 3-D isotropic capabilities and excellent multiplanar reconstructions. Three-Tesla (3T) MR scans enable high-resolution 3-D MR reconstructions for bone depiction similar to 3-D CT reconstructions and have the potential to eliminate the need for duplicate (CT and MR) scanning.
CONCLUSION: This technical report illustrates the feasibility of such an approach and compares bone rendering obtained using isotropic data from 3-D MR with 3-D CT in the same patient.

Entities:  

Mesh:

Year:  2015        PMID: 26377265

Source DB:  PubMed          Journal:  Radiol Technol        ISSN: 0033-8397


  2 in total

1.  Simulated radiographic bone and joint modeling from 3D ankle MRI: feasibility and comparison with radiographs and 2D MRI.

Authors:  Shaun M Nordeck; Conrad E Koerper; Aaron Adler; Vidur Malhotra; Yin Xi; George T Liu; Avneesh Chhabra
Journal:  Skeletal Radiol       Date:  2017-03-06       Impact factor: 2.199

2.  Does 3DMR provide equivalent information as 3DCT for the pre-operative evaluation of adult Hip pain conditions of femoroacetabular impingement and Hip dysplasia?

Authors:  Kevin Yan; Yin Xi; Chayanit Sasiponganan; Joseph Zerr; Joel E Wells; Avneesh Chhabra
Journal:  Br J Radiol       Date:  2018-08-07       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.